The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Cancer-related and treatment-related fatigue
Open accessAbstract
Fatigue is a distressing and persistent symptom for patients with gynecological cancer and for survivors. Debilitating cancer-related fatigue (CRF) is produced by both the disease and its treatment. Although awareness and study of CRF have grown in recent years, consistent assessment has not been a priority in routine medical practice. The pathophysiological mechanisms that induce CRF remain unclear, and effective pharmacological interventions have yet to be established. Based on the literature and our own research results, this review focuses on recent progress toward understanding the nature and causes of CRF and on several promising treatment modalities. Given the prevalence and severity of CRF in the gynecological cancer patient population, establishing standardized fatigue measurement and management methods in routine clinical oncology care is of utmost importance. Whether CRF has an underlying inflammatory cause is still hypothetical, however, and no mechanism-driven symptom intervention is currently in clinical use, even though the development of such interventions would provide patients with greater symptom control. Advancing translational and clinical fatigue research will require anatomical pathway studies and well-designed clinical investigations that focus on the development of mechanism-driven interventions based on physiological–behavioral fatigue research, implementation of guidelines for experimental designs, and discovery of biomarkers identifying individuals at high risk for CRF. Validated patient-reported outcomes measures are an essential component of such clinical studies. Because numerous subscales, unidimensional measures, and multidimensional measures exist, clinicians and researchers should consider individual circumstances, good clinical practice, and research goals as guides for choosing the most appropriate fatigue measurement tool. Additionally, education about CRF should be made available to all patients and their caregivers, as accurate and age-appropriate information about conditions like CRF can alleviate much of the stress and anxiety brought on by poor communication about this distressing condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
A meta‐analytic study of changes in brain activation in depression
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008) · Human Brain Mapping · doi:10.1002/hbm.20426 · Cited by 903
Controlled Physical Activity Trials in Cancer Survivors: A Systematic Review and Meta-analysis
Schmitz, K. H., Holtzman, J., Courneya, K. S., Mâsse, L. C., Duval, S., & Kane, R. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0703 · Cited by 638
Kangas, M., Bovbjerg, D. H., & Montgomery, G. H. (2008) · Psychological Bulletin · doi:10.1037/a0012825 · Cited by 428
Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.070 · Cited by 324 · cited 1×
“antidepressant paroxetine produced a significant reduction in depressive symptoms but not in fatigue [59]; however, Roscoe et al.”
BackgroundBower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., Arevalo, J., & Cole, S. W. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.019 · Cited by 283
Mind-Body Treatments for the Pain-Fatigue-Sleep Disturbance Symptom Cluster in Persons with Cancer
Kwekkeboom, K. L., Cherwin, C. H., Lee, J. W., & Wanta, B. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.05.022 · Cited by 228
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179 · cited 1×
“Studies of anti-inflammatory treatments to improve fatigue in cancer patients or survivors, such as TNF-α antagonists [32] and yoga [33], are providing increasing evidence for a translational approach to effective mechanismdriven symptom intervention.”
Background
Research works printed but not linked: 59
- Mendoza, 1999, The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory, Cancer, 85, 1186, 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N · DOI
- Servaes, 2007, The course of severe fatigue in disease-free breast cancer patients: a longitudinal study, Psychooncology, 16, 787, 10.1002/pon.1120 · DOI · Paper page
- Wang, 2014, Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors, Cancer, 120, 425, 10.1002/cncr.28434 · DOI · Paper page
- Alvarez, 2014, A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study, Gynecol Oncol, 133, 433, 10.1016/j.ygyno.2014.03.571 · DOI
- Martin, 2014, A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study, Gynecol Oncol, 132, 526, 10.1016/j.ygyno.2013.12.018 · doi:10.1016/j.ygyno.2013.12.018
- Anderson, 2008, Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors, Clin J Oncol Nurs, 12, 445, 10.1188/08.CJON.445-454 · doi:10.1188/08.cjon.445-454
- Williams, 2013, Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer, J Pain Symptom Manage, 46, 837, 10.1016/j.jpainsymman.2013.02.007 · DOI
- Sailors, 2013, Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer, Gynecol Oncol, 130, 323, 10.1016/j.ygyno.2013.05.009 · DOI
- Barsevick, 2010, ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials, J Pain Symptom Manage, 39, 1086, 10.1016/j.jpainsymman.2010.02.006 · DOI
- Mock, 2007, Cancer-related fatigue. Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 5, 1054, 10.6004/jnccn.2007.0088 · DOI · Paper page
- Wang, 2008, Pathophysiology of cancer-related fatigue, Clin J Oncol Nurs, 12, 11, 10.1188/08.CJON.S2.11-20 · DOI
- Given, 2001, Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients, J Pain Symptom Manage, 21, 456, 10.1016/S0885-3924(01)00284-6 · DOI · Paper page
- Peters, 2014, Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients, J Neurooncol, 10.1007/s11060-014-1574-3 · DOI
- Wang, 2006, Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms, J Clin Oncol, 24, 4485, 10.1200/JCO.2006.07.1126 · DOI
- Minton, 2012, Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set, J Pain Symptom Manage, 43, 226, 10.1016/j.jpainsymman.2011.03.025 · DOI
- Rubin, 2002, Systematic review and meta-analysis of interventions for postoperative fatigue, Br J Surg, 89, 971, 10.1046/j.1365-2168.2002.02138.x · DOI
- Shi, 2011, Symptom burden in cancer survivors 1year after diagnosis: a report from the American Cancer Society's Studies of cancer survivors, Cancer, 117, 2779, 10.1002/cncr.26146 · DOI · Paper page
- Téllez, 2008, The basal ganglia: a substrate for fatigue in multiple sclerosis, Neuroradiology, 50, 17, 10.1007/s00234-007-0304-3 · DOI
- Cleeland, 2003, Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?, Cancer, 97, 2919, 10.1002/cncr.11382 · DOI · Paper page
- Wang, 2008, Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation, Cancer, 113, 2102, 10.1002/cncr.23820 · DOI
- Sprangers, 2014, Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update, Qual Life Res, 23, 1997, 10.1007/s11136-014-0656-1 · DOI
- Whistler, 2006, Gene expression correlates of unexplained fatigue, Pharmacogenomics, 7, 395, 10.2217/14622416.7.3.395 · DOI
- Bower, 2011, Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue, Brain Behav Immun, 25, 147, 10.1016/j.bbi.2010.09.010 · DOI · Paper page
- Collado-Hidalgo, 2006, Inflammatory biomarkers for persistent fatigue in breast cancer survivors, Clin Cancer Res, 12, 2759, 10.1158/1078-0432.CCR-05-2398 · DOI · Paper page
- Schubert, 2007, The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review, Brain Behav Immun, 21, 413, 10.1016/j.bbi.2006.11.004 · DOI · Paper page
- Bower, 2011, Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?, J Clin Oncol, 29, 3517, 10.1200/JCO.2011.36.1154 · DOI · Paper page
- Wang, 2012, Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy, Brain Behav Immun, 26, 699, 10.1016/j.bbi.2011.12.007 · DOI
- Inagaki, 2008, Plasma interleukin-6 and fatigue in terminally ill cancer patients, J Pain Symptom Manage, 35, 153, 10.1016/j.jpainsymman.2007.03.009 · DOI
- Laird, 2013, The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer, Oncologist, 18, 1050, 10.1634/theoncologist.2013-0120 · DOI
- Irwin, 2007, Depressive disorders and immunity: 20years of progress and discovery, Brain Behav Immun, 21, 374, 10.1016/j.bbi.2007.01.010 · DOI · Paper page
- Payne, 2011, Altered circadian rhythms and cancer-related fatigue outcomes, Integr Cancer Ther, 10, 221, 10.1177/1534735410392581 · DOI
- Atkinson, 2012, Reliability of adverse symptom event reporting by clinicians, Qual Life Res, 21, 1159, 10.1007/s11136-011-0031-4 · DOI · Paper page
- Basch, 2009, Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes, J Natl Cancer Inst, 101, 1624, 10.1093/jnci/djp386 · DOI · Paper page
- Olson, 2007, A new way of thinking about fatigue: a reconceptualization, Oncol Nurs Forum, 34, 93, 10.1188/07.ONF.93-99 · DOI
- Cleeland, 1999, Measuring and understanding fatigue, Oncology, 13, 91
- Hjollund, 2007, Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales, Health Qual Life Outcomes, 5, 12, 10.1186/1477-7525-5-12 · DOI · Paper page
- Wang, 2010, Impact of cultural and linguistic factors on symptom reporting by patients with cancer, J Natl Cancer Inst, 102, 732, 10.1093/jnci/djq097 · DOI
- Lai, 2006, Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue, Qual Life Res, 15, 1179, 10.1007/s11136-006-0060-6 · DOI
- Krupp, 1989, The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus, Arch Neurol, 46, 1121, 10.1001/archneur.1989.00520460115022 · DOI · Paper page
- Smets, 1995, The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue, J Psychosom Res, 39, 315, 10.1016/0022-3999(94)00125-O · DOI · Paper page
- Ho, 2014, Cancer-related fatigue in breast cancer patients: factor mixture models with continuous non-normal distributions, Qual Life Res, 10.1007/s11136-014-0731-7 · DOI
- Serlin, 1995, When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function, Pain, 61, 277, 10.1016/0304-3959(94)00178-H · DOI · Paper page
- Cleeland, 1994, Pain and its treatment in outpatients with metastatic cancer, N Engl J Med, 330, 592, 10.1056/NEJM199403033300902 · DOI · Paper page
- Fisch, 2014, Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors, Cancer, 120, 442, 10.1002/cncr.28437 · DOI
- Denlinger, 2014, Survivorship: fatigue, version 1.2014, J Natl Compr Canc Netw, 12, 876, 10.6004/jnccn.2014.0082 · DOI
- De La Cruz, 2010, Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer, Cancer, 116, 766, 10.1002/cncr.24751 · DOI
- Minton, 2011, Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis, J Pain Symptom Manage, 41, 761, 10.1016/j.jpainsymman.2010.06.020 · DOI
- Gong, 2014, Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis, PLoS One, 9, e84391, 10.1371/journal.pone.0084391 · DOI
- Paulsen, 2014, Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial, J Clin Oncol, 10;32, 3221, 10.1200/JCO.2013.54.3926 · DOI · Paper page
- Jean-Pierre, 2010, Cancer, 116, 3513, 10.1002/cncr.25083 · DOI · Paper page
- Spathis, 2014, Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial, J Clin Oncol, 32, 1882, 10.1200/JCO.2013.54.4346 · DOI
- Roscoe, 2005, Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy, Breast Cancer Res Treat, 89, 243, 10.1007/s10549-004-2175-1 · DOI · Paper page
- Moss, 2006, An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners, Psychooncology, 15, 259, 10.1002/pon.952 · DOI
- Barton, 2013, Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2, J Natl Cancer Inst, 105, 1230, 10.1093/jnci/djt181 · DOI · Paper page
- Su, 2014, Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials, Complement Ther Med, 22, 567, 10.1016/j.ctim.2014.04.007 · DOI
- Jacobsen, 2007, Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue, Health Psychol, 26, 660, 10.1037/0278-6133.26.6.660 · DOI · Paper page
- Markes, 2006, Exercise for women receiving adjuvant therapy for breast cancer, Cochrane Database Syst Rev, CD005001
- Mustian, 2007, Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue, Oncologist, 12, 52, 10.1634/theoncologist.12-S1-52 · DOI · Paper page
- George, 2014, Better postdiagnosis diet quality is associated with less cancer-related fatigue in breast cancer survivors, J Cancer Surviv, 10.1007/s11764-014-0381-3 · DOI
Cited by
The biology of cancer-related fatigue: a review of the literature
Multinational Association of Supportive Care in Cancer Fatigue Study Group–Biomarker Working Group, Saligan, L. N., Olson, K., Filler, K., Larkin, D., Cramp, F., Sriram, Y., Escalante, C. P., del Giglio, A., Kober, K. M., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2763-0 · Cited by 296
Prevalence of Fatigue in Patients With Cancer: A Systematic Review and Meta-Analysis
Al Maqbali, M., Al Sinani, M., Al Naamani, Z., Al Badi, K., & Tanash, M. I. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.07.037 · Cited by 288
Fatigue, Sleep, and Autoimmune and Related Disorders
Zielinski, M. R., Systrom, D. M., & Rose, N. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01827 · Cited by 254
Auricular acupressure for cancer-related fatigue during lung cancer chemotherapy: a randomised trial
Lin, L., Zhang, Y., Qian, H. Y., Xu, J. L., Xie, C. Y., Dong, B., & Tian, L. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2019-001937 · Cited by 68
Clara, M. I., Stein, K., Canavarro, M. C., & Allen Gomes, A. (2023) · Acta Médica Portuguesa · doi:10.20344/amp.18797 · Cited by 5
Metadata
- Authors
- Wang, X. S., & Woodruff, J. F.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 136
- Issue
- 3
- Pages
- 446-452
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2055366832
- Cited by
- 172
- References
- 8
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institutes of Health (R21 CA158902)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer-related and treatment-related fatigue. https://app.cochat.ai/papers/10.1016/j.ygyno.2014.10.013
- The paper
- Wang, X. S., & Woodruff, J. F. (2015). Cancer-related and treatment-related fatigue. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2014.10.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.